BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• BioCapital

  It Looks As Though There’s Only One Thing Big Drug Companies Are Afraid Of

  October 20, 2016

   · 

  1 min read
• BioCapital

  Research On The Benefits Of Cannabis Has Been Sparse And The Results Are Mixed

  October 20, 2016

   · 

  1 min read
• Biotech Bay

  Digital Health Devices Are Great, But Their Prices Are Widening The Health Gap

  October 20, 2016

   · 

  1 min read
• Fujitsu Limited Is The Latest To Use AI In Healthcare With New DNA-Analyzing Computer

  October 20, 2016

   · 

  1 min read
• Biotech Beach

  Organovo Prices Approximately $25 Million Public Offering Of Common Stock

  October 20, 2016

   · 

  5 min read
• Business

  Innoviva Inc. To Report Third Quarter 2016 Financial Results On October 27 At 5:00 P.M. EDT

  October 20, 2016

   · 

  1 min read
• BioCapital

  Leonhard Lang GmbH and Welch Allyn’s Serious Recall Involves Incompatible Defibrillator Electrodes

  October 20, 2016

   · 

  1 min read
• Business

  Momenta Announces Date For Third Quarter 2016 Financial Results Conference Call And Webcast

  October 20, 2016

   · 

  1 min read
• Drug Development

  ProMetic Life Sci’s PBI-4050 Meets Primary And Secondary End Points In Metabolic Syndrome And Type 2 Diabetes Phase 2 Clinical Trial

  October 20, 2016

   · 

  7 min read
• Drug Development

  Theravance Biopharma And Mylan Announce Positive Results From Two Pivotal Phase 3 Studies Of Revefenacin (TD-4208) For The Treatment Of Chronic Obstructive Pulmonary Disease (COPD)

  October 20, 2016

   · 

  15 min read